ISTA Pharmaceuticals Receives FDA Approval for Bromday
Links shared publicly online about this topic.
- 787total visits
ISTA Pharmaceuticals Receives FDA Approval for Bromday
View full resource at drugs.com
Tags: Pain, Cataract, Drug, Pharma, FDA
Most Recently Shared on October 21, 2010 at 12:10 am By:
ISTA Pharmaceuticals Receives FDA Approval for Bromday: IRVINE, Calif., Oct. 16 /PRNewswire-FirstCall/ -- IST... http://bit.ly/a2xJ9h #drug
Breaking news: FDA approves first once-daily eyedrop for inflammation and pain after cataract surgery - - Drug Topics
drugtopics.modernmedicine.com — “Bromfenac ophthalmic solution (Bromday, ISTA Pharmaceuticals) 0.09% has been granted FDA approval as a once-daily prescription eyedrop for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on October 21, 2010 at 2:27 pm By:
Drugs and Devices OW OW Health
Breaking news: FDA approves first once-daily eyedrop for inflammation and pain after cataract surgery: Br... http://bit.ly/cO6qbt #drug
ISTA Pharmaceuticals Receives FDA Approval for Bromday
drugs.com — “Bromday (bromfenac ophthalmic solution) is used to treat postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction. Includes Bromday side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 21, 2010 at 1:08 am By:
ISTA Pharmaceuticals Receives FDA Approval for Bromday - http://bit.ly/9KROwW
ISTA Pharmaceuticals Receives FDA Approval For BROMDAY™
medicalnewstoday.com — “ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for BROMDAY™ (bromfenac” View full resource at medicalnewstoday.com
Most Recently Shared on October 19, 2010 at 1:05 pm By:
MNT Drug Approvals Health News
ISTA Pharmaceuticals Receives FDA Approval For BROMDAY™ http://mnt.to/3LpC #regulatory
ISTA's Bepreve™ Receives FDA Approval for Allergic Conjunctivitis
eyedocnews.com — “ISTA Pharmaceuticals, Inc. has announced that the FDA has approved Bepreve™1.5% as a twice a day prescription eye drop treatment for ocular itching associated with allergic conjunctivitis.” View full resource at eyedocnews.com
Most Recently Shared on September 17, 2009 at 9:36 am By:
Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician
Discuss: ISTA Pharmaceuticals’ Bepreve™ Receives FDA Approval For Ocular Itching Associated With Allergi.. http://bit.ly/2mdVSi
Ista Pharmaceuticals' Bepreve Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
drugs.com — “Bepreve (bepotastine besilate ophthalmic solution) is used to treat ocular itching associated with allergic conjunctivitis. Includes Bepreve side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 14, 2009 at 10:21 pm By:
FDA Approves Bepreve for the Treatment of Ocular Itching Due to Allergies - http://bit.ly/nfPSD
Advertisement
